Latest Market Segments News

Page 1 of 23
Saluda Medical delivered 28% FY26 revenue growth and expanded its spinal cord stimulation opportunity with CAP24, but its annual report warns that additional capital may be needed within 12 months. The ASX-listed medical device company also begins FY27 under new CEO Michael Mathias.
Victor Sage
Victor Sage
23 Oct 2026
Pro Medicus has signed a seven-year, A$24 million contract with Billings Clinic - Logan Health for a cloud-based deployment of its Visage 7 imaging platform. The transaction-based structure offers potential additional upside, although the announcement does not quantify future volumes or revenue timing.
Victor Sage
Victor Sage
19 Oct 2026
FirstWave Cloud Technology has lodged a provisional patent for an AI-driven network monitoring system that promises automated, explainable root cause diagnosis, aiming to boost its fastest-growing revenue stream.
Sophie Babbage
Sophie Babbage
4 Sept 2026
Magnetite Mines has unveiled a revamped scoping study for its Razorback Iron Ore Project, introducing key design changes to reduce capital costs and boost project viability. The company is also actively pursuing funding options including royalty arrangements and strategic partnerships.
Maxwell Dee
Maxwell Dee
4 Sept 2026
Sparc Technologies has made its inaugural commercial delivery of ecosparc®, a graphene additive, to a major coatings manufacturer, underpinning its push to dominate the protective coatings market. The company also launched a discounted Share Purchase Plan to fuel ongoing commercial expansion.
Victor Sage
Victor Sage
1 Sept 2026
SportsHero Limited reported a dramatic surge in revenue to AU$1.05 million for FY26, driven by new telco partnerships and the HeroPlay gaming platform launch, while losses increased 29% as the company ramped up marketing and development costs.
Sophie Babbage
Sophie Babbage
31 Aug 2026
Kina Securities lifted its half-year net profit by 4% to PGK 59.7 million, underpinned by a strong capital injection via Papua New Guinea’s inaugural listed corporate bond and a 13% higher interim dividend in local currency.
Claire Turing
Claire Turing
31 Aug 2026
4DMedical’s CT:VQ™ lung imaging technology secured FDA clearance and CMS reimbursement, driving rapid adoption in top US medical centres and expanding its addressable market to $3 billion with new clinical programs and European contracts.
Ada Torres
Ada Torres
28 Aug 2026
SomnoMed reported a 3% revenue rise to $114.5 million and a 19% EBITDA increase to $10.9 million in FY26, navigating European market headwinds and a CEO transition while launching its Virtus device targeting sleep apnea with bruxism.
Ada Torres
Ada Torres
28 Aug 2026
Saluda Medical delivered FY26 revenue of US$90.2 million, beating guidance with strong US and international growth, while reporting a flat net loss of US$149.6 million amid ongoing heavy investment. The company’s FDA approval of its CAP24 paddle lead opens a new US surgical market segment.
Ada Torres
Ada Torres
28 Aug 2026
Pengana Capital Group reported a statutory loss of $5.6 million for FY26 despite a 14% rise in funds under management, driven by upfront costs linked to new product launches and expanding private credit platforms.
Claire Turing
Claire Turing
26 Aug 2026
Ainsworth Game Technology’s first half 2026 results reveal a sharp revenue drop driven by North American and Latin American market pressures, offset partially by Asia Pacific growth and a key patent licensing deal.
Victor Sage
Victor Sage
26 Aug 2026

Browse the archive

Full archive